Nemaura Medical Inc logo

NMRD - Nemaura Medical Inc News Story

$4.82 0.7  17.0%

Last Trade - 3:26pm

Small Cap
Market Cap £72.4m
Enterprise Value £70.8m
Revenue £n/a
Position in Universe 5512th / 7335

Nemaura Medical Inc reports results for the quarter ended in March - Earnings Summary

Wed 7th July, 2021 9:40am
* Nemaura Medical Inc  NMRD.OQ  reported a quarterly adjusted
loss of 9 cents​​ per share for the quarter ended in March. The
lone analyst forecast for the quarter was for a loss of 8 cents
per share.
* Reported revenue was zero​;  analysts expected zero. 
* Nemaura Medical Inc's reported EPS for the quarter was a loss
of 9 cents​.
* The mean earnings estimate of analysts was unchanged in the
last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Nemaura Medical Inc shares had fallen by 15.0% this
quarter and gained 133.4% so far this year.
* The company reported a quarterly loss of $2.13 million.
* Wall Street's median 12-month price target for Nemaura Medical
Inc is $15.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated July 7 at 08:40 a.m.. ​All
figures in July 7
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.